BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 26629982)

  • 1. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
    Gujrati M; Vaidya A; Lu ZR
    Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Dual pH-Sensitive Lipid ECO/siRNA Self-Assembly Nanoparticles Facilitate In Vivo Cytosolic sieIF4E Delivery and Overcome Paclitaxel Resistance in Breast Cancer Therapy.
    Gujrati M; Vaidya AM; Mack M; Snyder D; Malamas A; Lu ZR
    Adv Healthc Mater; 2016 Nov; 5(22):2882-2895. PubMed ID: 27723260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.
    Sato Y; Hashiba K; Sasaki K; Maeki M; Tokeshi M; Harashima H
    J Control Release; 2019 Feb; 295():140-152. PubMed ID: 30610950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environment-Responsive Lipid/siRNA Nanoparticles for Cancer Therapy.
    Lu ZR; Laney VEA; Hall R; Ayat N
    Adv Healthc Mater; 2021 Mar; 10(5):e2001294. PubMed ID: 33615743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multifunctional Envelope-Type Nano Device Containing a pH-Sensitive Cationic Lipid for Efficient Delivery of Short Interfering RNA to Hepatocytes In Vivo.
    Sato Y; Harashima H; Kohara M
    Methods Mol Biol; 2016; 1364():71-8. PubMed ID: 26472443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery.
    Malamas AS; Gujrati M; Kummitha CM; Xu R; Lu ZR
    J Control Release; 2013 Nov; 171(3):296-307. PubMed ID: 23796431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrophobic scaffolds of pH-sensitive cationic lipids contribute to miscibility with phospholipids and improve the efficiency of delivering short interfering RNA by small-sized lipid nanoparticles.
    Sato Y; Okabe N; Note Y; Hashiba K; Maeki M; Tokeshi M; Harashima H
    Acta Biomater; 2020 Jan; 102():341-350. PubMed ID: 31733331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery.
    Wang XL; Ramusovic S; Nguyen T; Lu ZR
    Bioconjug Chem; 2007; 18(6):2169-77. PubMed ID: 17939730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Size-dependent specific targeting and efficient gene silencing in peritoneal macrophages using a pH-sensitive cationic liposomal siRNA carrier.
    Matsui H; Sato Y; Hatakeyama H; Akita H; Harashima H
    Int J Pharm; 2015 Nov; 495(1):171-178. PubMed ID: 26355712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release.
    Gujrati M; Malamas A; Shin T; Jin E; Sun Y; Lu ZR
    Mol Pharm; 2014 Aug; 11(8):2734-44. PubMed ID: 25020033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of an efficient short interference RNA (siRNA) delivery system with a new pH-sensitive cationic lipid].
    Sato Y; Hatakeyama H; Hyodo M; Akita H; Harashima H
    Yakugaku Zasshi; 2012; 132(12):1355-63. PubMed ID: 23208041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-based nanoparticles in the systemic delivery of siRNA.
    Lin Q; Chen J; Zhang Z; Zheng G
    Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice.
    Wang XL; Xu R; Wu X; Gillespie D; Jensen R; Lu ZR
    Mol Pharm; 2009; 6(3):738-46. PubMed ID: 19296675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-based siRNA Delivery Systems: Challenges, Promises and Solutions Along the Long Journey.
    Sarisozen C; Salzano G; Torchilin VP
    Curr Pharm Biotechnol; 2016; 17(8):728-40. PubMed ID: 27033509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.
    Sato Y; Matsui H; Sato R; Harashima H
    J Control Release; 2018 Aug; 284():179-187. PubMed ID: 29936118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
    Ku SH; Kim K; Choi K; Kim SH; Kwon IC
    Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.
    Cheng X; Lee RJ
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):129-137. PubMed ID: 26900977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo.
    Sato Y; Hatakeyama H; Sakurai Y; Hyodo M; Akita H; Harashima H
    J Control Release; 2012 Nov; 163(3):267-76. PubMed ID: 23000694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes.
    Hashiba K; Sato Y; Harashima H
    J Control Release; 2017 Sep; 262():239-246. PubMed ID: 28774839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.